Cardiol Therapeutics (NASDAQ:CRDL) Receives Buy Rating from HC Wainwright
Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $9.00 price objective on the stock. Other equities research analysts have also issued research reports about the stock. Rodman & Renshaw assumed […]
Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They currently have a $9.00 price objective on the stock. Other equities research analysts have also issued research reports about the stock. Rodman & Renshaw assumed […]
